pharma news today glp-1 obesity biotech Therapies Reshape Future of Healthcare Dozens of new obesity drugs

Another drugmaker, Amgen, is testing a different drug that could be given monthly or possibly even quarterly

Properties of Retatrutide: Molecular Formula: C221H342N46O68 Molecular Weight: 4731 g/mol CAS Number: 2381089-83-2 PubChem CID: 171390338 Synonyms: 2381089-83-2, LY3437943, Triple G, orb1981169, EX-A7826E Research Applications/Benefits of Retatrutide Metabolic Regulation Retatrutide is being investigated for its potential to influence metabolic pathways in preclinical models

Semaglutide, more commonly known by the brand names Ozempic, Rybelsus, and Wegovy is a glucagon-like peptide-1 (GLP-1) agonist that has been used for several years in the management of type 2 diabetes mellitus (T2DM)

It operates outside of standard Part D coverage, meaning you don't receive medications through your regular prescription drug plan